Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84

1.

Self-assembly of mitochondria-specific peptide amphiphiles amplifying lung cancer cell death through targeting the VDAC1-hexokinase-II complex.

Liu D, Angelova A, Liu J, Garamus VM, Angelov B, Zhang X, Li Y, Feger G, Li N, Zou A.

J Mater Chem B. 2019 Jul 31;7(30):4706-4716. doi: 10.1039/c9tb00629j.

PMID:
31364685
2.

Neuronal integration in the adult mouse olfactory bulb is a non-selective addition process.

Platel JC, Angelova A, Bugeon S, Wallace J, Ganay T, Chudotvorova I, Deloulme JC, Béclin C, Tiveron MC, Coré N, Murthy VN, Cremer H.

Elife. 2019 Jul 11;8. pii: e44830. doi: 10.7554/eLife.44830.

3.

Immune System Stimulation by Oncolytic Rodent Protoparvoviruses.

Angelova A, Rommelaere J.

Viruses. 2019 May 4;11(5). pii: E415. doi: 10.3390/v11050415. Review.

4.

Characterization of perinatally born glutamatergic neurons of the mouse olfactory bulb based on NeuroD6 expression reveals their resistance to sensory deprivation.

Angelova A, Platel JC, Béclin C, Cremer H, Coré N.

J Comp Neurol. 2019 May 1;527(7):1245-1260. doi: 10.1002/cne.24621. Epub 2019 Jan 16.

PMID:
30592042
5.

Amphiphilic Nanocarrier Systems for Curcumin Delivery in Neurodegenerative Disorders.

Rakotoarisoa M, Angelova A.

Medicines (Basel). 2018 Nov 23;5(4). pii: E126. doi: 10.3390/medicines5040126. Review.

6.

In situ phase transition of microemulsions for parenteral injection yielding lyotropic liquid crystalline carriers of the antitumor drug bufalin.

Li Y, Angelova A, Liu J, Garamus VM, Li N, Drechsler M, Gong Y, Zou A.

Colloids Surf B Biointerfaces. 2019 Jan 1;173:217-225. doi: 10.1016/j.colsurfb.2018.09.023. Epub 2018 Sep 11.

PMID:
30296646
7.

Liquid Crystalline Nanostructures as PEGylated Reservoirs of Omega-3 Polyunsaturated Fatty Acids: Structural Insights toward Delivery Formulations against Neurodegenerative Disorders.

Angelova A, Drechsler M, Garamus VM, Angelov B.

ACS Omega. 2018 Mar 31;3(3):3235-3247. doi: 10.1021/acsomega.7b01935. Epub 2018 Mar 16.

8.

ASSESSMENT OF RESIDENTIAL RADON EXPOSURE IN BULGARIA.

Kunovska B, Ivanova K, Badulin V, Cenova M, Angelova A.

Radiat Prot Dosimetry. 2018 Sep 1;181(1):34-37. doi: 10.1093/rpd/ncy098.

PMID:
29905863
9.

Tailoring acyclovir prodrugs with enhanced antiviral activity: rational design, synthesis, human plasma stability and in vitro evaluation.

Chayrov RL, Stylos EK, Chatziathanasiadou MV, Chuchkov KN, Tencheva AI, Kostagianni AD, Milkova TS, Angelova AL, Galabov AS, Shishkov SA, Todorov DG, Tzakos AG, Stankova IG.

Amino Acids. 2018 Aug;50(8):1131-1143. doi: 10.1007/s00726-018-2590-y. Epub 2018 May 19.

PMID:
29779181
10.

Neuronal Subtype Generation During Postnatal Olfactory Bulb Neurogenesis.

Angelova A, Tiveron MC, Cremer H, Beclin C.

J Exp Neurosci. 2018 Feb 27;12:1179069518755670. doi: 10.1177/1179069518755670. eCollection 2018.

11.

Immunotherapeutic Potential of Oncolytic H-1 Parvovirus: Hints of Glioblastoma Microenvironment Conversion towards Immunogenicity.

Angelova AL, Barf M, Geletneky K, Unterberg A, Rommelaere J.

Viruses. 2017 Dec 15;9(12). pii: E382. doi: 10.3390/v9120382.

12.

Zic-Proteins Are Repressors of Dopaminergic Forebrain Fate in Mice and C. elegans.

Tiveron MC, Beclin C, Murgan S, Wild S, Angelova A, Marc J, Coré N, de Chevigny A, Herrera E, Bosio A, Bertrand V, Cremer H.

J Neurosci. 2017 Nov 1;37(44):10611-10623. doi: 10.1523/JNEUROSCI.3888-16.2017. Epub 2017 Sep 29.

13.

Oncolytic H-1 Parvovirus Shows Safety and Signs of Immunogenic Activity in a First Phase I/IIa Glioblastoma Trial.

Geletneky K, Hajda J, Angelova AL, Leuchs B, Capper D, Bartsch AJ, Neumann JO, Schöning T, Hüsing J, Beelte B, Kiprianova I, Roscher M, Bhat R, von Deimling A, Brück W, Just A, Frehtman V, Löbhard S, Terletskaia-Ladwig E, Fry J, Jochims K, Daniel V, Krebs O, Dahm M, Huber B, Unterberg A, Rommelaere J.

Mol Ther. 2017 Dec 6;25(12):2620-2634. doi: 10.1016/j.ymthe.2017.08.016. Epub 2017 Aug 24.

14.

A non-controlled, single arm, open label, phase II study of intravenous and intratumoral administration of ParvOryx in patients with metastatic, inoperable pancreatic cancer: ParvOryx02 protocol.

Hajda J, Lehmann M, Krebs O, Kieser M, Geletneky K, Jäger D, Dahm M, Huber B, Schöning T, Sedlaczek O, Stenzinger A, Halama N, Daniel V, Leuchs B, Angelova A, Rommelaere J, Engeland CE, Springfeld C, Ungerechts G.

BMC Cancer. 2017 Aug 29;17(1):576. doi: 10.1186/s12885-017-3604-y.

15.

Dual and multi-drug delivery nanoparticles towards neuronal survival and synaptic repair.

Angelova A, Angelov B.

Neural Regen Res. 2017 Jun;12(6):886-889. doi: 10.4103/1673-5374.208546. Review.

16.

Nanoscale clustering of the neurotrophin receptor TrkB revealed by super-resolution STED microscopy.

Angelov B, Angelova A.

Nanoscale. 2017 Jul 20;9(28):9797-9804. doi: 10.1039/c7nr03454g.

PMID:
28682396
17.

Enhanced crude oil biodegradative potential of natural phytoplankton-associated hydrocarbonoclastic bacteria.

Thompson H, Angelova A, Bowler B, Jones M, Gutierrez T.

Environ Microbiol. 2017 Jul;19(7):2843-2861. doi: 10.1111/1462-2920.13811. Epub 2017 Jul 7.

PMID:
28585283
18.

The Oncolytic Virotherapy Era in Cancer Management: Prospects of Applying H-1 Parvovirus to Treat Blood and Solid Cancers.

Angelova AL, Witzens-Harig M, Galabov AS, Rommelaere J.

Front Oncol. 2017 May 12;7:93. doi: 10.3389/fonc.2017.00093. eCollection 2017.

19.

Advances in structural design of lipid-based nanoparticle carriers for delivery of macromolecular drugs, phytochemicals and anti-tumor agents.

Angelova A, Garamus VM, Angelov B, Tian Z, Li Y, Zou A.

Adv Colloid Interface Sci. 2017 Nov;249:331-345. doi: 10.1016/j.cis.2017.04.006. Epub 2017 Apr 18. Review.

PMID:
28477868
20.

Self-assembled stable sponge-type nanocarries for Brucea javanica oil delivery.

Zou A, Li Y, Chen Y, Angelova A, Garamus VM, Li N, Drechsler M, Angelov B, Gong Y.

Colloids Surf B Biointerfaces. 2017 May 1;153:310-319. doi: 10.1016/j.colsurfb.2017.02.031. Epub 2017 Feb 27.

PMID:
28285062
21.

Effectiveness of High Intensity Laser Therapy for Reduction of Pain in Knee Osteoarthritis.

Angelova A, Ilieva EM.

Pain Res Manag. 2016;2016:9163618. doi: 10.1155/2016/9163618. Epub 2016 Dec 20.

22.

In Vitro Modulation of TrkB Receptor Signaling upon Sequential Delivery of Curcumin-DHA Loaded Carriers Towards Promoting Neuronal Survival.

Guerzoni LP, Nicolas V, Angelova A.

Pharm Res. 2017 Feb;34(2):492-505. doi: 10.1007/s11095-016-2080-4. Epub 2016 Dec 19.

PMID:
27995523
23.

Establishment and Characterization of a Novel Cell Line, ASAN-PaCa, Derived From Human Adenocarcinoma Arising in Intraductal Papillary Mucinous Neoplasm of the Pancreas.

Heller A, Angelova AL, Bauer S, Grekova SP, Aprahamian M, Rommelaere J, Volkmar M, Janssen JW, Bauer N, Herr I, Giese T, Gaida MM, Bergmann F, Hackert T, Fritz S, Giese NA.

Pancreas. 2016 Nov;45(10):1452-1460.

PMID:
27518460
24.

Mesoporous self-assembled nanoparticles of biotransesterified cyclodextrins and nonlamellar lipids as carriers of water-insoluble substances.

Zerkoune L, Lesieur S, Putaux JL, Choisnard L, Gèze A, Wouessidjewe D, Angelov B, Vebert-Nardin C, Doutch J, Angelova A.

Soft Matter. 2016 Sep 13;12(36):7539-7550.

PMID:
27714323
25.

The Promise of Gene Therapy for Pancreatic Cancer.

Vassaux G, Angelova A, Baril P, Midoux P, Rommelaere J, Cordelier P.

Hum Gene Ther. 2016 Feb;27(2):127-33. doi: 10.1089/hum.2015.141. Review.

PMID:
26603492
26.

RiTE database: a resource database for genus-wide rice genomics and evolutionary biology.

Copetti D, Zhang J, El Baidouri M, Gao D, Wang J, Barghini E, Cossu RM, Angelova A, Maldonado L CE, Roffler S, Ohyanagi H, Wicker T, Fan C, Zuccolo A, Chen M, Costa de Oliveira A, Han B, Henry R, Hsing YI, Kurata N, Wang W, Jackson SA, Panaud O, Wing RA.

BMC Genomics. 2015 Jul 22;16:538. doi: 10.1186/s12864-015-1762-3.

27.

Tumor Selectivity of Oncolytic Parvoviruses: From in vitro and Animal Models to Cancer Patients.

Angelova AL, Geletneky K, Nüesch JP, Rommelaere J.

Front Bioeng Biotechnol. 2015 Apr 22;3:55. doi: 10.3389/fbioe.2015.00055. eCollection 2015. Review.

28.

Double-faceted mechanism of parvoviral oncosuppression.

Geletneky K, Nüesch JP, Angelova A, Kiprianova I, Rommelaere J.

Curr Opin Virol. 2015 Aug;13:17-24. doi: 10.1016/j.coviro.2015.03.008. Epub 2015 Apr 2. Review.

PMID:
25841215
29.

Identification of large channels in cationic PEGylated cubosome nanoparticles by synchrotron radiation SAXS and Cryo-TEM imaging.

Angelov B, Angelova A, Drechsler M, Garamus VM, Mutafchieva R, Lesieur S.

Soft Matter. 2015 May 14;11(18):3686-92. doi: 10.1039/c5sm00169b.

PMID:
25820228
30.

Genome Sequence of Polycyclovorans algicola Strain TG408, an Obligate Polycyclic Aromatic Hydrocarbon-Degrading Bacterium Associated with Marine Eukaryotic Phytoplankton.

Gutierrez T, Thompson HF, Angelova A, Whitman WB, Huntemann M, Copeland A, Chen A, Kyrpides N, Markowitz V, Palaniappan K, Ivanova N, Mikhailova N, Ovchinnikova G, Andersen E, Pati A, Stamatis D, Reddy TB, Ngan CY, Chovatia M, Daum C, Shapiro N, Cantor MN, Woyke T.

Genome Announc. 2015 Mar 26;3(2). pii: e00207-15. doi: 10.1128/genomeA.00207-15.

31.

Diet shapes the gut microbiota of the omnivorous cockroach Blattella germanica.

Pérez-Cobas AE, Maiques E, Angelova A, Carrasco P, Moya A, Latorre A.

FEMS Microbiol Ecol. 2015 Apr;91(4). pii: fiv022. doi: 10.1093/femsec/fiv022. Epub 2015 Feb 26.

PMID:
25764470
32.

Oncolytic parvoviruses: from basic virology to clinical applications.

Marchini A, Bonifati S, Scott EM, Angelova AL, Rommelaere J.

Virol J. 2015 Jan 29;12:6. doi: 10.1186/s12985-014-0223-y. Review.

33.
34.

Multicompartment lipid cubic nanoparticles with high protein upload: millisecond dynamics of formation.

Angelov B, Angelova A, Filippov SK, Drechsler M, Štěpánek P, Lesieur S.

ACS Nano. 2014 May 27;8(5):5216-26. doi: 10.1021/nn5012946. Epub 2014 Apr 17.

PMID:
24742149
35.

Complementary induction of immunogenic cell death by oncolytic parvovirus H-1PV and gemcitabine in pancreatic cancer.

Angelova AL, Grekova SP, Heller A, Kuhlmann O, Soyka E, Giese T, Aprahamian M, Bour G, Rüffer S, Cziepluch C, Daeffler L, Rommelaere J, Werner J, Raykov Z, Giese NA.

J Virol. 2014 May;88(10):5263-76. doi: 10.1128/JVI.03688-13. Epub 2014 Feb 26.

36.

From molecular to nanotechnology strategies for delivery of neurotrophins: emphasis on brain-derived neurotrophic factor (BDNF).

Géral C, Angelova A, Lesieur S.

Pharmaceutics. 2013 Feb 8;5(1):127-67. doi: 10.3390/pharmaceutics5010127.

37.

Neurotrophin delivery using nanotechnology.

Angelova A, Angelov B, Drechsler M, Lesieur S.

Drug Discov Today. 2013 Dec;18(23-24):1263-71. doi: 10.1016/j.drudis.2013.07.010. Epub 2013 Jul 23. Review.

PMID:
23891881
38.

Protein entrapment in PEGylated lipid nanoparticles.

Angelova A, Angelov B, Drechsler M, Garamus VM, Lesieur S.

Int J Pharm. 2013 Oct 1;454(2):625-32. doi: 10.1016/j.ijpharm.2013.06.006. Epub 2013 Jun 17.

PMID:
23791734
39.

DNA/Fusogenic Lipid Nanocarrier Assembly: Millisecond Structural Dynamics.

Angelov B, Angelova A, Filippov SK, Narayanan T, Drechsler M, Štěpánek P, Couvreur P, Lesieur S.

J Phys Chem Lett. 2013 Jun 6;4(11):1959-64. doi: 10.1021/jz400857z. Epub 2013 May 28.

PMID:
26283134
40.

Quatsomes: vesicles formed by self-assembly of sterols and quaternary ammonium surfactants.

Ferrer-Tasies L, Moreno-Calvo E, Cano-Sarabia M, Aguilella-Arzo M, Angelova A, Lesieur S, Ricart S, Faraudo J, Ventosa N, Veciana J.

Langmuir. 2013 Jun 4;29(22):6519-28. doi: 10.1021/la4003803. Epub 2013 May 21.

PMID:
23647396
41.

Earliest stage of the tetrahedral nanochannel formation in cubosome particles from unilamellar nanovesicles.

Angelov B, Angelova A, Garamus VM, Drechsler M, Willumeit R, Mutafchieva R, Štěpánek P, Lesieur S.

Langmuir. 2012 Dec 4;28(48):16647-55. doi: 10.1021/la302721n. Epub 2012 Nov 14.

PMID:
23148665
42.

Protein-containing PEGylated cubosomic particles: freeze-fracture electron microscopy and synchrotron radiation circular dichroism study.

Angelov B, Angelova A, Papahadjopoulos-Sternberg B, Hoffmann SV, Nicolas V, Lesieur S.

J Phys Chem B. 2012 Jul 5;116(26):7676-86. doi: 10.1021/jp303863q. Epub 2012 Jun 21.

PMID:
22720820
43.

Small-Angle X-ray Scattering Investigations of Biomolecular Confinement, Loading, and Release from Liquid-Crystalline Nanochannel Assemblies.

Angelova A, Angelov B, Garamus VM, Couvreur P, Lesieur S.

J Phys Chem Lett. 2012 Feb 2;3(3):445-57. doi: 10.1021/jz2014727. Epub 2012 Jan 24.

PMID:
26285865
44.

Interferon γ improves the vaccination potential of oncolytic parvovirus H-1PV for the treatment of peritoneal carcinomatosis in pancreatic cancer.

Grekova SP, Aprahamian M, Daeffler L, Leuchs B, Angelova A, Giese T, Galabov A, Heller A, Giese NA, Rommelaere J, Raykov Z.

Cancer Biol Ther. 2011 Nov 15;12(10):888-95. doi: 10.4161/cbt.12.10.17678. Epub 2011 Nov 15.

45.

Regulation of the new Arabidopsis imprinted gene AtBMI1C requires the interplay of different epigenetic mechanisms.

Bratzel F, Yang C, Angelova A, López-Torrejón G, Koch M, del Pozo JC, Calonje M.

Mol Plant. 2012 Jan;5(1):260-9. doi: 10.1093/mp/ssr078. Epub 2011 Sep 13.

46.

Pancreatic cancer cell lines can induce prostaglandin e2 production from human blood mononuclear cells.

Grekova SP, Angelova A, Daeffler L, Raykov Z.

J Oncol. 2011;2011:741868. doi: 10.1155/2011/741868. Epub 2011 Jul 12.

47.

Self-assembled multicompartment liquid crystalline lipid carriers for protein, peptide, and nucleic acid drug delivery.

Angelova A, Angelov B, Mutafchieva R, Lesieur S, Couvreur P.

Acc Chem Res. 2011 Feb 15;44(2):147-56. doi: 10.1021/ar100120v. Epub 2010 Dec 29. Review.

PMID:
21189042
48.

SAXS investigation of a cubic to a sponge (L3) phase transition in self-assembled lipid nanocarriers.

Angelov B, Angelova A, Mutafchieva R, Lesieur S, Vainio U, Garamus VM, Jensen GV, Pedersen JS.

Phys Chem Chem Phys. 2011 Feb 28;13(8):3073-81. doi: 10.1039/c0cp01029d. Epub 2010 Nov 16.

PMID:
21079857
49.

Cholesterol induced CTAB micelle-to-vesicle phase transitions.

Cano-Sarabia M, Angelova A, Ventosa N, Lesieur S, Veciana J.

J Colloid Interface Sci. 2010 Oct 1;350(1):10-5. doi: 10.1016/j.jcis.2010.04.069. Epub 2010 Jul 16.

PMID:
20638071
50.

Oncolytic parvoviruses as cancer therapeutics.

Rommelaere J, Geletneky K, Angelova AL, Daeffler L, Dinsart C, Kiprianova I, Schlehofer JR, Raykov Z.

Cytokine Growth Factor Rev. 2010 Apr-Jun;21(2-3):185-95. doi: 10.1016/j.cytogfr.2010.02.011. Epub 2010 Mar 7. Review.

PMID:
20211577

Supplemental Content

Loading ...
Support Center